| Followers | 25 |
| Posts | 2128 |
| Boards Moderated | 0 |
| Alias Born | 03/07/2014 |
Sunday, December 03, 2023 2:45:56 PM
"On November 30, 2023, Tenax Therapeutics, Inc. (the “Company”) convened the Company’s special meeting of stockholders (the “Special Meeting”). At the Special Meeting, stockholders voted on the proposal to approve an amendment to the Company’s certificate of incorporation, as amended, to authorize a reverse stock split of each issued and outstanding share of the Company’s common stock by a ratio of not less than one-for-ten (1:10) and not more than one-for-eighty (1:80), with the exact ratio to be determined by the Board in its sole discretion. The Board may implement or abandon this amendment no later than November 30, 2024. The vote for this proposal was 6,198,812 shares for, 5,364,151 shares against, 23,186 shares abstaining, and no broker non-votes."
https://app.quotemedia.com/data/downloadFiling?webmasterId=102691&ref=317904642&type=HTML&symbol=TENX&cdn=272fc8ab5e97a2d5904ad6eae6c2e4a6&companyName=Tenax+Therapeutics+Inc.&formType=424B3&formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&dateFiled=2023-12-01
Recent TENX News
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/10/2026 10:02:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 11:48:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 11:32:44 AM
- Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/10/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/09/2026 04:24:22 PM
- Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2026 06:21:10 PM
- Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 • GlobeNewswire Inc. • 02/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:49:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:14:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:46:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:29:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:03:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 12:53:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 09:33:28 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/23/2025 09:30:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 10:00:18 PM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
